Securities code: Chongqing Lummy Pharmaceutical Co.Ltd(300006) securities abbreviation: Chongqing Lummy Pharmaceutical Co.Ltd(300006) Announcement No.: 2022009 Chongqing Lummy Pharmaceutical Co.Ltd(300006)
Announcement of resolutions of the 18th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
According to the notice of the 18th meeting of the 5th board of supervisors issued by the board of supervisors of Chongqing Lummy Pharmaceutical Co.Ltd(300006) (hereinafter referred to as "the company") on March 14, 2022, the board of supervisors of the company was held on March 24, 2022 in the form of on-site meeting and communication voting. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The meeting was convened and held in accordance with the company law of the people's Republic of China, the articles of association and relevant laws and regulations. The meeting was presided over by Ms. yuan yuan, chairman of the board of supervisors of the company. After deliberation and written vote one by one by the supervisors present at the meeting, the following resolutions were formed:
1、 The work report of the board of supervisors in 2021 was reviewed and adopted
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Disclosed the work report of the board of supervisors in 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This report needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
2、 The proposal on 2021 annual report and summary was deliberated and adopted
After review, the board of supervisors of the company believes that the preparation and review procedures of the 2021 annual report and summary of the company comply with laws, administrative regulations and the provisions of the CSRC, and the contents of the report truly, accurately and completely reflect the actual situation of the company, without false records, misleading statements or major omissions.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Disclosed annual report 2021 and summary of annual report 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
3、 The proposal on the financial final accounts report of 2021 was deliberated and adopted
The board of supervisors believes that the financial statement of the company in 2021 truly and objectively reflects the financial status and operating results of the company. For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Disclosed financial final accounts report of 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
4、 The proposal on the provision for asset impairment in 2021 was reviewed and approved
The board of supervisors believes that the company's provision for asset impairment this time complies with the accounting standards for business enterprises and other relevant provisions, and truly reflects the company's financial situation, asset value and operating results. It conforms to the actual situation of the company and does not damage the interests of the company and shareholders.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Announcement on the provision for asset impairment in 2021 and other matters disclosed.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
5、 The proposal on renewing the appointment of accounting firms was deliberated and adopted
The board of supervisors believes that in order to maintain the continuity of the audit work, it agrees to renew the appointment of Sichuan Huaxin (Group) accounting firm (special general partnership) as the company's accounting firm in 2022 for one year, and the audit fee in 2022 is expected to be 870000 yuan.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）The announcement on renewing the appointment of accounting firms disclosed.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
6、 The proposal on the profit distribution plan for 2021 was reviewed and approved
The annual profit distribution plan for 2021 proposed by the company is: no cash dividend, no bonus shares, and no capital reserve converted into share capital.
The board of supervisors believes that the company's profit distribution plan for 2021 is formulated in accordance with the actual situation of the company, in line with the relevant provisions of the company law and the articles of association, and in line with the needs of the company's operation and development.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Special instructions on the company's intention not to make profit distribution in 2021 disclosed.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
7、 The proposal on submitting to the general meeting of shareholders to authorize the board of directors to approve the guarantee for subsidiaries was reviewed and adopted. After deliberation, the board of supervisors believed that the guarantee provided the company with financing guarantee for holding subsidiaries (including wholly-owned subsidiaries), would not increase the company's consolidated report contingent liabilities, and the funds obtained from the guarantee were used for production and operation, which was conducive to the business development of subsidiaries and the related risks were controllable. Agree to submit the matter to the general meeting of shareholders of the company for deliberation.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Announcement on submitting to the general meeting of shareholders to authorize the board of directors to approve the guarantee for subsidiaries disclosed.
Voting results: 0 votes, 3 abstentions.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
8、 The proposal on the evaluation report of internal control in 2021 was considered and adopted
After reviewing the 2021 internal control evaluation report of the company, the board of supervisors issued the following verification opinions: the company has established a relatively perfect internal control system, which meets the requirements of relevant national laws and regulations and the actual needs of the company's production management and operation, and can be effectively implemented. The establishment of the internal control system has played a good role in risk prevention and control in all links of the company's operation and management. The internal control evaluation report of the company truly and objectively reflects the construction and operation of the company's internal control system.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）2021 internal control evaluation report and relevant announcements disclosed.
Voting results: 3 in favor, 0 against and 0 abstention.
9、 The proposal on the special report on the deposit and use of raised funds in 2021 was reviewed and adopted. According to the guidelines for the supervision of listed companies No. 2 - regulatory requirements for the management and use of raised funds by listed companies The relevant provisions of Shenzhen Stock Exchange GEM listed companies self regulatory guidelines No. 2 announcement format: No. 21 special report format for the annual deposit and use of raised funds of listed companies and the guidelines for self regulatory supervision of listed companies No. 2 - standardized operation of GEM listed companies, The company issued the special report on the deposit and use of raised funds in 2021 on the deposit and use of raised funds in 2021.
After review, the supervisors attending the meeting held that the deposit and use of the company's raised funds in 2021 comply with the provisions of relevant laws, regulations and normative documents, and have been disclosed in a timely manner as required. There are no violations in the use and management of the raised funds.
For details, please refer to the company's website on the same day（ http://www.cn.info.com.cn. ）Special report on the deposit and use of raised funds in 2021 and relevant announcements.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Chongqing Lummy Pharmaceutical Co.Ltd(300006) board of supervisors March 25, 2022
